Proposal for Streamlined U.S. Regulatory Approval for Novel Commercial Space Activities Tyler S. Cox Office of Space Commerce (“OSC”) has released a proposal for streamlining regulatory approval of novel commercial…

AI Risks With the Patent Office: What Life Science Companies Should Be Asking Now Robert J. Hilton, Ph.D. & Justin Culbertson, Ph.D. AI tools are reshaping patent preparation and prosecution,…

WASHINGTON, D.C., June 1, 2026 – Knobbe Martens is pleased to share that four of the firm’s lawyers have been recognized by Washington, D.C. Super Lawyers. William Zimmerman was named…

IRVINE, Calif., May 29, 2026 – Knobbe Martens is pleased to share that Sheila Swaroop, Chair of Knobbe Martens’ Litigation practice, was named the “North America Patent Lawyer of the…

In the Law360 article “How Patent Eligibility Declarations Can Stave Off Rejection,” Knobbe Martens partner Philip Nelson discussed the practical impacts of the U.S. Patent and Trademark Office’s recent update…

In a recent article published in Law360, Knobbe Martens lawyers Joshua Martineau and Jarom Kesler explore the U.S. Patent and Trademark Office (USPTO)’s latest guidance regarding ex parte reexamination (EPR)…

IRVINE, Calif., May 28, 2026 – Knobbe Martens, a leading intellectual property law firm, and its partners were once again recognized for excellence across patent law in the 2026 edition…

In a recent MLex article on The Sedona Conference’s model jury instructions for federal litigation under the Defend Trade Secrets Act (DTSA), Knobbe Martens partner Sheila Swaroop shared insights on…

Key Takeaway: The USPTO’s new PIER Pilot Program requires applicants in selected PCT national stage applications to affirmatively decide whether to proceed with, delay, or abandon U.S. patent examination. Participation…

WASHINGTON, D.C., May 21, 2026 – A team from Knobbe Martens secured a substantial appellate victory on behalf of Lupin Ltd., ensuring patients a cost-effective option for treating life-threatening kidney…